Clinical Trial Update: Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports results from a Phase 2 study evaluating repeated intravitreal VEGF Trap (aflibercept) injections for wet age-related macu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• VEGF Trap (aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2012-03-01